Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD—results from COSYCONET

Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD—results from COSYCONET

Abstract Background MRproANP and COPAVP are prognostic markers for mortality in chronic obstructive pulmonary disease (COPD). Furthermore, these biomarkers predict mortality due to cardiovascular diseases, which are important prognostically determining comorbidities in patients with COPD. However, l...

Full description

Bibliographic Details
Main Authors: S. Fähndrich, C. Herr, S. Teuteberg, P. Alter, S. Söhler, D. Soriano, J. Classen, J. Adams, V. Weinhold, H. Watz, B. Waschki, T. Zeller, M. Eichenlaub, F. C. Trudzinski, J. D. Michels, A. Omlor, F. Seiler, I. Moneke, F. Biertz, D. Stolz, T. Welte, H. U. Kauczor, K. Kahnert, R. A. Jörres, C. F. Vogelmeier, R. Bals, the German COSYCONET Cohort
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Respiratory Research
Subjects:
COPD
Mortality
MRproADM
COPAVP
MRproANP
Prospective multicenter cohort study
Online Access:https://doi.org/10.1186/s12931-024-02690-9

Internet

https://doi.org/10.1186/s12931-024-02690-9

Similar Items